Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.11889/8421
Title: Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries
Authors: Dehghan, Mahshid 
Mente, Andrew 
Rangarajan, Sumathy 
Mohan, Viswanathan 
Lear, Scott 
Swaminathan, Sumathi 
Wielgosz, Andreas 
Seron, Pamela 
Avezum, Alvaro 
Lopez-Jaramillo, Patricio 
Turbide, Ginette 
Chifamba, Jephat 
AlHabib, Khalid F. 
Mohammadifard, Noushin 
Szuba, Andrzej 
Khatib, Rasha 
Altuntas, Yuksel 
Liu, Xiaoyun 
Iqbal, Romaina 
Rosengren, Annika 
Yusuf, Rita 
Smuts, Marius 
Yusufali, AfzalHussein 
Li, Ning 
Rafael Diaz,26 
Yusoff, Khalid 
Kaur, Manmeet 
Soman, Biju 
Ismail, Noorhassim 
Gupta, Rajeev 
Dans, Antonio 
Sheridan, Patrick 
Teo, Koon 
Anand, Sonia S. 
Yusuf, Salim 
Keywords: Eggs - Health aspects;Blood cholesterol;Cholesterol - Health aspects;Blood lipids;Blood lipoproteins;Cardiovascular diseases - Mortality - Prevention
Issue Date: 2020
Publisher: American Journal of Clinical Nutrition
Abstract: Background: Eggs are a rich source of essential nutrients, but they are also a source of dietary cholesterol. Therefore, some guidelines recommend limiting egg consumption. However, there is contradictory evidence on the impact of eggs on diseases, largely based on studies conducted in high-income countries. Objectives: Our aim was to assess the association of egg consumption with blood lipids, cardiovascular disease (CVD), and mortality in large global studies involving populations from low-, middle-, and high-income countries. Methods: We studied 146,011 individuals from 21 countries in the Prospective Urban Rural Epidemiology (PURE) study. Egg consumption was recorded using country-specific validated FFQs. We also studied 31,544 patients with vascular disease in 2 multinational prospective studies: ONTARGET (Ongoing Telmisartan Alone and in Combination with Ramipril Global End Point Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in ACEI Intolerant Subjects with Cardiovascular Disease). We calculated HRs using multivariable Cox frailty models with random intercepts to account for clustering by study center separately within each study. Results: In the PURE study, we recorded 14,700 composite events (8932 deaths and 8477 CVD events). In the PURE study, after excluding those with history of CVD, higher intake of egg (≥7 egg/wk compared with <1 egg/wk intake) was not significantly associated with blood lipids, composite outcome (HR: 0.96; 95% CI: 0.89, 1.04; P-trend = 0.74), total mortality (HR: 1.04; 95% CI: 0.94, 1.15; P-trend = 0.38), or major CVD (HR: 0.92; 95% CI: 0.83, 1.01; P-trend = 0.20). Similar results were observed in ONTARGET/TRANSCEND studies for composite outcome (HR 0.97; 95% CI: 0.76, 1.25; P-trend = 0.09), total mortality (HR: 0.88; 95% CI: 0.62, 1.24; P-trend=0.55), and major CVD(HR: 0.97; 95% CI: 0.73, 1.29; P-trend = 0.12).Conclusions: In 3 large international prospective studies including ∼177,000 individuals, 12,701 deaths, and 13,658 CVD events from 50 countries in 6 continents, we did not find significant associations between egg intake and blood lipids, mortality, or major CVD events. The ONTARGET and TRANSCEND trials were registered at clinicaltrials.gov as NCT00153101. The PURE trial was registered at clinicaltrials.gov as NCT03225586. Am J Clin Nutr 2020;00:1–9.
URI: http://hdl.handle.net/20.500.11889/8421
DOI: 10.1093/ajcn/nqz348
Appears in Collections:Fulltext Publications

Show full item record

Page view(s)

15
checked on Jun 18, 2024

Download(s)

5
checked on Jun 18, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.